Randomized clinical trial: efficacy and safety of plecanatide in the treatment of chronic idiopathic constipation.

Ther Adv Gastroenterol · 2017 · PMC5673020 · PMID 29147135

Europe PMC DOI

hedged sentence

0.0540

closest p · 1.1× alpha

0.0540

boldest claim

The sentences

narrowly missed statistical significancep = 0.054so close (0.05 < p ≤ 0.1)

There was a statistically greater improvement from baseline in the severity of abdominal bloating at week 12 with plecanatide 3 mg ( p = 0.007), and abdominal discomfort narrowly missed statistical significance ( p = 0.054).

also in 227 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.